At the time of writing, Elevance Health Inc [ELV] stock is trading at $422.04, up 3.05%. An important factor to consider is whether the stock is rising or falling in short-term value. The ELV shares have gain 6.24% over the last week, with a monthly amount glided 7.82%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Elevance Health Inc [NYSE: ELV] stock has seen the most recent analyst activity on January 22, 2025, when Stephens downgraded its rating to a Equal-Weight and also revised its price target to $440 from $520. Previously, Argus downgraded its rating to Hold on October 18, 2024. On July 18, 2024, downgrade downgraded it’s rating to Neutral and revised its price target to $530 on the stock. Morgan Stanley started tracking the stock assigning a Overweight rating and suggested a price target of $643 on June 24, 2024. Robert W. Baird initiated its recommendation with a Outperform and recommended $649 as its price target on May 30, 2024. Barclays started tracking with a Overweight rating for this stock on March 06, 2024, and assigned it a price target of $584. In a note dated July 12, 2023, Wolfe Research downgraded an Peer Perform rating on this stock.
For the past year, the stock price of Elevance Health Inc fluctuated between $362.21 and $567.26. Currently, Wall Street analysts expect the stock to reach $525.33 within the next 12 months. Elevance Health Inc [NYSE: ELV] shares were valued at $422.04 at the most recent close of the market. An investor can expect a potential return of 24.47% based on the average ELV price forecast.
Analyzing the ELV fundamentals
According to Elevance Health Inc [NYSE:ELV], the company’s sales were 176.81B for trailing twelve months, which represents an 6.55% jump. Gross Profit Margin for this corporation currently stands at 0.47% with Operating Profit Margin at 0.05%, Pretax Profit Margin comes in at 0.04%, and Net Profit Margin reading is 0.03%. To continue investigating profitability, this company’s Return on Assets is posted at 0.05, Equity is 0.14 and Total Capital is 0.1. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.76.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 413.52 points at the first support level, and at 405.00 for the second support level. However, for the 1st resistance point, the stock is sitting at 429.04, and for the 2nd resistance point, it is at 436.05.
Ratios To Look Out For
It is important to note that Elevance Health Inc [NYSE:ELV] has a current ratio of 1.45. Considering the valuation of this stock, the price to sales ratio is 0.54, the price to book ratio is 2.32 and price to earnings (TTM) ratio is 16.48.
Transactions by insiders
Recent insider trading involved Penczek Ronald W, CAO & Controller, that happened on Mar 10 ’25 when 443.0 shares were sold. Officer, Penczek Ronald W completed a deal on Mar 10 ’25 to buy 443.0 shares. Meanwhile, EVP & President, Commercial Kendrick Charles Morgan JR sold 3504.0 shares on Mar 05 ’25.
